title: Modulation of diethylnitrosamine carcinogenesis in rat liver and oesophagus.
abstract: A series of 16 experiments, using a total of 2,000 BD6 rats, was designed in order to assess the ability of 8 individual agents or their combinations to modulate the liver and oesophageal carcinogenesis induced by multiple doses of diethylnitrosamine (DEN). Of the antioxidants tested, sodium selenite, ascorbic acid, and butylated hydroxytoluene generally exhibited protective effects on both types of tumors. In contrast, retinoic acid behaved as a promoter of DEN hepatocarcinogenesis, but this effect could be eliminated by its combination with either selenite or butylated hydroxytoluene. Caffeine and theophylline, when individually assayed, were devoid of significant protective effects, and the latter methylxanthine stimulated oesophageal tumorigenesis when administered after exposure to the carcinogen. Caffeine tended to decrease the multiplicity of liver tumors and potentiated the inhibitory effect of selenite in the liver. Irrespective of combination with caffeine, treatment with phenobarbital before each DEN injection tended to reduce the multiplicity of both liver and oesophageal tumors. On the other hand, the metabolic inhibitor diethyldithiocarbamate, given after each DEN injection, dramatically enhanced the incidence and multiplicity of oesophageal tumors. Thus, on the whole, modulation of DEN carcinogenesis varied depending on test agents, their combinations, dosages, treatment schedules, and target organ.
authors.affiliation: National Centre of Oncology, Sofia, Bulgaria.
authors.forename: R M
authors.initials: RM
authors.lastname: Balansky
authors.forename: P M
authors.initials: PM
authors.lastname: Blagoeva
authors.forename: Z I
authors.initials: ZI
authors.lastname: Mircheva
authors.forename: S
authors.initials: S
authors.lastname: De Flora
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D004052:Diethylnitrosamine; D004195:Disease Models, Animal; D004938:Esophageal Neoplasms / Q000517:prevention & control*; D005260:Female; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013534:Survival; D013806:Theophylline / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D000975:Antioxidants; D002110:Caffeine; D004052:Diethylnitrosamine; D014212:Tretinoin; D013806:Theophylline; D001205:Ascorbic Acid; D010634:Phenobarbital